Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Gastrointestinal Cancers – Pancreatic / Gastric / Esophageal / Liver / Biliary
-
-
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
-
Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction
-
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
-
Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
-
Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
-
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
-
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
-
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
-
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
Categories
Alliance Committee
Browse by Year